Camp4 Therapeutics (CAMP) Asset Utilization Ratio (2024 - 2026)

Camp4 Therapeutics' (CAMP) quarterly Asset Utilization Ratio came in at 0.04 in Q1 2026, up 64.63% year-on-year from 0.02 in Q1 2025, and up 2.86% quarter-over-quarter from 0.03 in Q4 2025.

Camp4 Therapeutics (CAMP) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Camp4 Therapeutics has disclosed Asset Utilization Ratio across 3 years of filings, most recently posting 0.04 for Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.04, up 64.63% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.04 (up 64.63% YoY), and the FY2025 annual result was 0.04, up 264.53% from the prior year.
  • Asset Utilization Ratio came in at 0.04 for Q1 2026 at Camp4 Therapeutics, up from 0.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.06 in Q3 2025 to a low of 0.01 in Q4 2024.
  • The 3-year median for Asset Utilization Ratio is 0.03 (2025), against an average of 0.04.
  • Across the five-year window, Asset Utilization Ratio surged 161.87% in 2025 and soared 64.63% in 2026, its largest moves.
  • Camp4 Therapeutics' Asset Utilization Ratio stood at 0.01 in 2024, then soared by 161.87% to 0.03 in 2025, then gained by 2.86% to 0.04 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.04 (Q1 2026), 0.03 (Q4 2025), and 0.06 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 0.55
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 1,422.00
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 0.47
9 Abivax 90.15 Bn 90.15 Bn - -
10 Camp4 Therapeutics 245.02 Mn 245.02 Mn - 0.04

Historic Data

Download Data
DateValue
Mar 31, 2026 0.04
Dec 31, 2025 0.03
Sep 30, 2025 0.06
Jun 30, 2025 0.05
Mar 31, 2025 0.02
Dec 31, 2024 0.01